FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron

Argentina Noticias Noticias

FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron
Argentina Últimas Noticias,Argentina Titulares
  • 📰 ABC7Chicago
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 63%

The FDA revoked emergency authorization for COVID-19 monoclonal antibody drugs from Regeneron and Eli Lilly for being ineffective against omicron.

WASHINGTON -- COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.

Omicron's resistance to the two leading monoclonal antibody medicines has upended the treatment playbook for COVID-19 in recent weeks. The FDA noted in its decision that omicron accounts for more than 99% of U.S. infections, making it"highly unlikely" the antibodies would help people now seeking treatment. The agency said restricting their use would also eliminate unnecessary drug side effects, including allergic reactions.

The drugs are not a substitute for vaccination and are generally reserved for people who are the most vulnerable, including seniors, transplant recipients and those with conditions like heart disease and diabetes. The move comes days after regulators broadened the use of remdesivir - the first drug approved for COVID-19 - to treat more patients.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

ABC7Chicago /  🏆 284. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronFDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronCOVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant, U.S. health officials said.
Leer más »

Eli Apple torpedoes Giants, Saints in unfiltered tweetstormEli Apple torpedoes Giants, Saints in unfiltered tweetstormBengals cornerback Eli Apple wrapped up his playoff weekend by dumping on his former teams, the Giants and Saints.
Leer más »

Across The Shield: Eli Apple Makes Game-Changing Pass Deflection, Nick Bosa Sacks Aaron Rodgers Twice As Bengals, 49ers Make Conference Championship GamesAcross The Shield: Eli Apple Makes Game-Changing Pass Deflection, Nick Bosa Sacks Aaron Rodgers Twice As Bengals, 49ers Make Conference Championship GamesEli Apple makes a game-changing pass deflection and Nick Bosa sacks Aaron Rodgers twice as the Bengals and 49ers pull off upset wins to advance to conference championship games.
Leer más »

Skull Session: Jim Tressel Dumps on Jim Harbaugh, Ohio State Owns the AP Poll, and Eli Apple's Personality Has Come AliveSkull Session: Jim Tressel Dumps on Jim Harbaugh, Ohio State Owns the AP Poll, and Eli Apple's Personality Has Come AliveSkull Session: Jim Tressel gives Jim Harbaugh a 1-star review, Ohio State owns the AP Poll, Eli Apple's had an incredible heel turn, and more.
Leer más »

FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronFDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronCOVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant, U.S. health officials said.
Leer más »

FDA halts use of antibody drugs that don't work against omicronFDA halts use of antibody drugs that don't work against omicronCOVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant. Doctors have alternate therapies, including two new antiviral pills from Pfizer and Merck, but both are in short supply.
Leer más »



Render Time: 2025-03-26 18:06:45